References
- Fielden KE, Newton JM, Rowe RC. The influence of lactose particle-size on spheronization of extrudate processed by a ram extruder. Int J Pharm 1992;81:205–224.
- Shah RD, Kabadi M, Pope DG, Augsburger LL. Physicomechanical characterization of the extrusion-spheronization process. 2. Rheological determinants for successful extrusion and spheronization. Pharm Res 1995;12:496–507.
- Pinto JF, Buckton G, Newton JM. The influence of 4 selected processing and formulation factors on the production of spheres by extrusion and spheronization. Int J Pharm 1992;83:187–196.
- Millili GP, Schwartz JB. The strength of microcrystalline cellulose pellets – the effect of granulating with water ethanol mixtures. Drug Dev Ind Pharm 1990;16:1411–1426.
- Souto C, Rodriguez A, Parajes S, Martinez-Pacheco R. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm 2005;61:94–99.
- Vervaet C, Baert L, Remon JP. Enhancement of in-vitro drug-release by using polyethylene-glycol-400 and peg-40 hydrogenated castor-oil in pellets made by extrusion/spheronisation. Int J Pharm 1994;108:207–212.
- Schroder M, Kleinebudde P. Influence of formulation parameters on dissolution of propyphenazone pellets. Eur J Pharm Biopharm 1995;41:382–387.
- Lindner H, Kleinebudde P. Use of powdered cellulose for the production of pellets by extrusion spheronization. J Pharm Pharmacol 1994;46:2–7.
- Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug. Eur J Pharm Biopharm 2003;55:291–295.
- Tho I, Sande SA, Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation. Eur J Pharm Biopharm 2003;56:371–380.
- Thommes M, Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur J Pharm Biopharm 2006;63:59–67.
- Dukic-Ott A, Remon JP, Foreman P, Vervaet C. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Eur J Pharm Biopharm 2007;67:715–724.
- Howard MA, Neau SH, Sack MJ. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. Int J Pharm 2006;307:66–76.
- Ku CC, Joshi YM, Bergum JS, Jain NB. Bead manufacture by extrusion spheronization – a statistical design for process optimization. Drug Dev Ind Pharm 1993;19:1505–1519.
- Sousa JJ, Sousa A, Podczeck F, Newton JM. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm 2002;232:91–106.
- Fielden KE, Newton JM, Rowe RC. The effect of lactose particle-size on the extrusion properties of microcrystalline cellulose-lactose mixtures. J Pharm Pharmacol 1989;41:217–221.
- Fielden KE, Newton JM, Rowe RC. The influence of moisture-content on spheronization of extrudate processed by a ram extruder. Int J Pharm 1993;97:79–92.
- Dyer AM, Khan KA, Aulton ME. Effect of the drying method on the mechanical and drug-release properties of pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm 1994;20:3045–3068.
- Baert L, Fanara D, Remon JP, Massart D. Correlation of extrusion forces, raw-materials and sphere characteristics. J Pharm Pharmacol 1992;44:676–678.
- Wan LSC, Heng PWS, Liew CV. Spheronization conditions on spheroid shape and size. Int J Pharm 1993;96:59–65.
- Iyer RM, Augsburger LL, Pope DG, Shah RD. Extrusion/spheronization-effect of moisture content and spheronization time on pellet characteristics. Pharm Dev Tech 1996;1:325–331.
- Hasznos L. The effect of drug load, type of microcrystalline cellulose and lactose particle size on selected pellet characteristics. Pharmazie 1998;53:423.
- Sandri G, Maria CB, Ferrari F, Rossi S, Caramella C. Differentiating factors between oral fast-dissolving technologies. Am J Drug Deliv 2006;4:249–262.
- Yalkowsky SH, He Y. Handbook of aqueous solubility data. Boca Raton: CRC Press; 2003.
- Dukic A, Mens R, Adriaensens P, et al. Development of starch-based pellets via extrusion/spheronisation. Eur J Pharm Biopharm 2007;66:83–94.
- Exner HE, Linck E. Image analysis for characterization of size-distribution and shape-distribution of lead powders. Powder Metall Int 1977;9:131–133.
- Fayed FM, Otten L. Handbook of powder science and technology. New York: Van Nostrand Reinhold; 1984.
- Svarovsky L. Powder testing guide: Methods of measuring the physical properties of bulk powders. London: Elsevier Applied Science; 1987.
- Khan KA, Rhodes CT. Effect of compaction pressure on dissolution efficiency of some direct compression systems. Pharm Acta Helv 1972;47:594–607.
- Dokoumetzidis A, Papadopoulou V, Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull Function. Pharm Res 2006;23:256–261.
- Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R. Effect of micro crystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm 2002;28:451–456.
- Sinha VR, Kumria R, Agrawal MK. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Curr Drug Deliv 2005;2:1–8.
- Lustig-Gustafsson C, Johal HK, Podczeck F, Newton JM. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation. Eur J Pharm Sci 1999;8:147–152.